Financhill
Sell
21

ERMAF Quote, Financials, Valuation and Earnings

Last price:
$58.50
Seasonality move :
-2.19%
Day range:
$58.50 - $58.50
52-week range:
$50.00 - $63.57
Dividend yield:
2.55%
P/E ratio:
104.37x
P/S ratio:
0.53x
P/B ratio:
1.38x
Volume:
--
Avg. volume:
10
1-year change:
7.31%
Market cap:
$1.7B
Revenue:
$3.2B
EPS (TTM):
-$3.70

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ERMAF
Eramet SA
-- -- -- -- --
AIQUY
Air Liquide SA
$7.7B -- -- -- $48.36
ARKAY
Arkema SA
$2.5B -- -0.45% -- $87.00
CSTM
Constellium SE
$2.1B $0.37 22.71% 2380.02% $19.99
VLOWY
Vallourec SA
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ERMAF
Eramet SA
$58.50 -- $1.7B 104.37x $1.49 2.55% 0.53x
AIQUY
Air Liquide SA
$37.82 $48.36 $109B 29.34x $0.75 1.97% 3.67x
ARKAY
Arkema SA
$59.70 $87.00 $4.5B 28.61x $4.07 6.82% 0.44x
CSTM
Constellium SE
$17.77 $19.99 $2.4B 22.11x $0.00 0% 0.32x
VLOWY
Vallourec SA
$3.75 -- $4.5B 11.82x $0.34 9.05% 1.12x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ERMAF
Eramet SA
69.74% 0.191 -- 0.71x
AIQUY
Air Liquide SA
31.73% -0.173 -- 0.51x
ARKAY
Arkema SA
46.67% 0.361 126.15% 2.03x
CSTM
Constellium SE
71.62% 2.006 103.07% 0.45x
VLOWY
Vallourec SA
31.12% 0.662 -- 0.95x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ERMAF
Eramet SA
-- -- -2.38% -4.93% -- --
AIQUY
Air Liquide SA
-- -- 9.2% 13.24% -- --
ARKAY
Arkema SA
$474.4M $125M 1.19% 2.09% 4.89% $174.2M
CSTM
Constellium SE
$230M $133M 3.94% 13.75% 6.14% $25.3M
VLOWY
Vallourec SA
$324.3M $157.6M 10.28% 14.6% 16.11% $69.4M

Eramet SA vs. Competitors

  • Which has Higher Returns ERMAF or AIQUY?

    Air Liquide SA has a net margin of -- compared to Eramet SA's net margin of --. Eramet SA's return on equity of -4.93% beat Air Liquide SA's return on equity of 13.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    ERMAF
    Eramet SA
    -- -- $4.9B
    AIQUY
    Air Liquide SA
    -- -- $42.9B
  • What do Analysts Say About ERMAF or AIQUY?

    Eramet SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Air Liquide SA has an analysts' consensus of $48.36 which suggests that it could grow by 20.77%. Given that Air Liquide SA has higher upside potential than Eramet SA, analysts believe Air Liquide SA is more attractive than Eramet SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ERMAF
    Eramet SA
    0 0 0
    AIQUY
    Air Liquide SA
    1 0 0
  • Is ERMAF or AIQUY More Risky?

    Eramet SA has a beta of 0.136, which suggesting that the stock is 86.358% less volatile than S&P 500. In comparison Air Liquide SA has a beta of 0.850, suggesting its less volatile than the S&P 500 by 15%.

  • Which is a Better Dividend Stock ERMAF or AIQUY?

    Eramet SA has a quarterly dividend of $1.49 per share corresponding to a yield of 2.55%. Air Liquide SA offers a yield of 1.97% to investors and pays a quarterly dividend of $0.75 per share. Eramet SA pays 275.99% of its earnings as a dividend. Air Liquide SA pays out 38.68% of its earnings as a dividend. Air Liquide SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Eramet SA's is not.

  • Which has Better Financial Ratios ERMAF or AIQUY?

    Eramet SA quarterly revenues are --, which are smaller than Air Liquide SA quarterly revenues of --. Eramet SA's net income of -- is lower than Air Liquide SA's net income of --. Notably, Eramet SA's price-to-earnings ratio is 104.37x while Air Liquide SA's PE ratio is 29.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eramet SA is 0.53x versus 3.67x for Air Liquide SA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ERMAF
    Eramet SA
    0.53x 104.37x -- --
    AIQUY
    Air Liquide SA
    3.67x 29.34x -- --
  • Which has Higher Returns ERMAF or ARKAY?

    Arkema SA has a net margin of -- compared to Eramet SA's net margin of 1.6%. Eramet SA's return on equity of -4.93% beat Arkema SA's return on equity of 2.09%.

    Company Gross Margin Earnings Per Share Invested Capital
    ERMAF
    Eramet SA
    -- -- $4.9B
    ARKAY
    Arkema SA
    18.56% $0.54 $13.7B
  • What do Analysts Say About ERMAF or ARKAY?

    Eramet SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Arkema SA has an analysts' consensus of $87.00 which suggests that it could grow by 45.73%. Given that Arkema SA has higher upside potential than Eramet SA, analysts believe Arkema SA is more attractive than Eramet SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ERMAF
    Eramet SA
    0 0 0
    ARKAY
    Arkema SA
    1 0 0
  • Is ERMAF or ARKAY More Risky?

    Eramet SA has a beta of 0.136, which suggesting that the stock is 86.358% less volatile than S&P 500. In comparison Arkema SA has a beta of 0.908, suggesting its less volatile than the S&P 500 by 9.194%.

  • Which is a Better Dividend Stock ERMAF or ARKAY?

    Eramet SA has a quarterly dividend of $1.49 per share corresponding to a yield of 2.55%. Arkema SA offers a yield of 6.82% to investors and pays a quarterly dividend of $4.07 per share. Eramet SA pays 275.99% of its earnings as a dividend. Arkema SA pays out 62% of its earnings as a dividend. Arkema SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Eramet SA's is not.

  • Which has Better Financial Ratios ERMAF or ARKAY?

    Eramet SA quarterly revenues are --, which are smaller than Arkema SA quarterly revenues of $2.6B. Eramet SA's net income of -- is lower than Arkema SA's net income of $40.9M. Notably, Eramet SA's price-to-earnings ratio is 104.37x while Arkema SA's PE ratio is 28.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eramet SA is 0.53x versus 0.44x for Arkema SA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ERMAF
    Eramet SA
    0.53x 104.37x -- --
    ARKAY
    Arkema SA
    0.44x 28.61x $2.6B $40.9M
  • Which has Higher Returns ERMAF or CSTM?

    Constellium SE has a net margin of -- compared to Eramet SA's net margin of 4.06%. Eramet SA's return on equity of -4.93% beat Constellium SE's return on equity of 13.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    ERMAF
    Eramet SA
    -- -- $4.9B
    CSTM
    Constellium SE
    10.62% $0.63 $3B
  • What do Analysts Say About ERMAF or CSTM?

    Eramet SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Constellium SE has an analysts' consensus of $19.99 which suggests that it could grow by 13.59%. Given that Constellium SE has higher upside potential than Eramet SA, analysts believe Constellium SE is more attractive than Eramet SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ERMAF
    Eramet SA
    0 0 0
    CSTM
    Constellium SE
    2 1 0
  • Is ERMAF or CSTM More Risky?

    Eramet SA has a beta of 0.136, which suggesting that the stock is 86.358% less volatile than S&P 500. In comparison Constellium SE has a beta of 1.551, suggesting its more volatile than the S&P 500 by 55.058%.

  • Which is a Better Dividend Stock ERMAF or CSTM?

    Eramet SA has a quarterly dividend of $1.49 per share corresponding to a yield of 2.55%. Constellium SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eramet SA pays 275.99% of its earnings as a dividend. Constellium SE pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ERMAF or CSTM?

    Eramet SA quarterly revenues are --, which are smaller than Constellium SE quarterly revenues of $2.2B. Eramet SA's net income of -- is lower than Constellium SE's net income of $88M. Notably, Eramet SA's price-to-earnings ratio is 104.37x while Constellium SE's PE ratio is 22.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eramet SA is 0.53x versus 0.32x for Constellium SE. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ERMAF
    Eramet SA
    0.53x 104.37x -- --
    CSTM
    Constellium SE
    0.32x 22.11x $2.2B $88M
  • Which has Higher Returns ERMAF or VLOWY?

    Vallourec SA has a net margin of -- compared to Eramet SA's net margin of 4.64%. Eramet SA's return on equity of -4.93% beat Vallourec SA's return on equity of 14.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    ERMAF
    Eramet SA
    -- -- $4.9B
    VLOWY
    Vallourec SA
    33.14% $0.04 $3.6B
  • What do Analysts Say About ERMAF or VLOWY?

    Eramet SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Vallourec SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Eramet SA has higher upside potential than Vallourec SA, analysts believe Eramet SA is more attractive than Vallourec SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ERMAF
    Eramet SA
    0 0 0
    VLOWY
    Vallourec SA
    0 0 0
  • Is ERMAF or VLOWY More Risky?

    Eramet SA has a beta of 0.136, which suggesting that the stock is 86.358% less volatile than S&P 500. In comparison Vallourec SA has a beta of 0.404, suggesting its less volatile than the S&P 500 by 59.6%.

  • Which is a Better Dividend Stock ERMAF or VLOWY?

    Eramet SA has a quarterly dividend of $1.49 per share corresponding to a yield of 2.55%. Vallourec SA offers a yield of 9.05% to investors and pays a quarterly dividend of $0.34 per share. Eramet SA pays 275.99% of its earnings as a dividend. Vallourec SA pays out 60.03% of its earnings as a dividend. Vallourec SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Eramet SA's is not.

  • Which has Better Financial Ratios ERMAF or VLOWY?

    Eramet SA quarterly revenues are --, which are smaller than Vallourec SA quarterly revenues of $978.6M. Eramet SA's net income of -- is lower than Vallourec SA's net income of $45.4M. Notably, Eramet SA's price-to-earnings ratio is 104.37x while Vallourec SA's PE ratio is 11.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eramet SA is 0.53x versus 1.12x for Vallourec SA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ERMAF
    Eramet SA
    0.53x 104.37x -- --
    VLOWY
    Vallourec SA
    1.12x 11.82x $978.6M $45.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock